All posts by: MarksMan Healthcare

About MarksMan Healthcare

MarksMan Healthcare Communications

Affirming the economy is on the right track, India’s finance minister Arun Jaitley presented the union budget 2016-2017 on 29 Feb 2016.  The budget has been a mixed bag overall. The major focus is on rural progress, infrastructure and public sector which definitely acts as catalyst towards the economy. On the healthcare front, the prominence […]

On the eve of “World Rare Disease Day” today, February 29, 2016 (the rarest day of the year), I planned to post a two series blog post on “Orphan Drug Pricing and Reimbursement” During 1970, individual patients and volunteer healthcare organizations began lobbying for legislation to encourage the development of therapies for rare diseases.  The […]

Medical devices may well sound like a modern invention but they have helped us control and treat diseases for centuries. Medical gadgets play a considerable role in our lives, many of them so ubiquitous that we at times take them for granted. Some of the examples for such medical devices include clinical thermometer, hypodermic needle, […]

The high cost of pharmaceuticals, especially biologics, has become an important issue in the battle to control healthcare costs. In order to overcome this impediment, biosimilar unlike generics were first marketed in Europe in the year 2007. The Affordable Care Act (ACA), which includes the Biologics Price Competition and Innovation Act (BPCIA), defines biosimilar as having […]

To most connected with the pharmaceutical industry, it is a common knowledge that the cost of prescription medicine, even traditionally, has always defied the law of gravity. However; what is alarming today is the steep increase in the cost of specialty drugs that target everything from multiple sclerosis to cancer, blood pressure, and even erectile […]